Skip to main content

Table 2 Baseline demographic, clinical and laboratory characteristics of the studied patients

From: Prognostic implications of IDH1rs11554137 and IDH2R140Q SNPs mutations in cytogenetically normal acute myeloid leukemia

Age (years) Mean ± SD 45 ± 16
Gender N (%)  
 Male   56 (70)
 Female   24 (30)
Hepatomegaly N (%)  
 Negative   43 (53.8)
 Positive   37 (46.2)
Splenomegaly N (%)  
 Negative   29 (36.3)
 Positive   51 (63.7)
Lymphadenopathy N (%)  
 Negative   54 (67.5)
 Positive   26 (32.5)
Hemoglobin (g/dl) Mean ± SD 6.8 ± 1.6
TLC (× 109/L) Mean ± SD 69 ± 41.7
Platelets (× 109/L) Mean ± SD 30 ± 17
Blast cells (%) Mean ± SD 72.2 ± 16.3
FAB Classification N (%)  
 M1   11 (13.8)
 M2   44 (55)
 M4   19 (23.8)
 M5   6 (7)
Time from diagnosis (days) Mean ± SD 94 ± 78
  1. N number, SD standard deviation, TLC total leucocytic count